Clinical Trial Update: Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing Gemcitabine plus Oxaliplatin to Oxaliplatin plus Fluorouracil/Leucovorin for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gemcitabine + Oxaliplatin
• Oxaliplatin + Fluorouracil/Leucovorin

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: WITHDRAWN